SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-21-000260
Filing Date
2021-02-23
Accepted
2021-02-23 13:50:08
Documents
1
Effectiveness Date
2021-02-23

Document Format Files

Seq Description Document Type Size
1 8A_Cert_BCTX.pdf CERT 108619
  Complete submission text file 0001354457-21-000260.txt   150879
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: CERT | Act: 34 | File No.: 001-40101 | Film No.: 21664459
SIC: 2834 Pharmaceutical Preparations